Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy.
Clin Infect Dis
; 71(1): 207-210, 2020 06 24.
Article
em En
| MEDLINE
| ID: mdl-31603189
ABSTRACT
The OVIVA study demonstrated noninferiority for managing bone and joint infections (BJIs) with oral antibiotics. We report that 79.7% of OPAT patients being treated for BJIs at our center would be eligible for oral antibiotics, saving a median (IQR) 19.5 IV-antibiotic days (8.5-37) and GBP 1234 (569-2594) per patient.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Artrite Infecciosa
/
Anti-Infecciosos
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article